New drug duo aims to block Cancer's growth pathways
NCT ID NCT05038839
Summary
This is an early-stage study to find the safest dose of two oral drugs, cabozantinib and pamiparib, when given together. It is for adults with advanced solid tumors that have spread or stopped responding to standard treatments. The goal is to see if blocking multiple cancer growth signals at once is safe and can help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT SOLID NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.